Source: TCmake_photo / Getty Images
Source: TCmake_photo / Getty Images

Technological advances have led to dramatic decreases in the cost of genetic sequencing, ushering in a genomics revolution that aspires to transform medicine. However, developing solutions that can effectively, efficiently, and affordably translate these advances to a clinical setting remains challenging, which is why two genomics companies, Congenica and Edico Genome, have partnered to offer their complementary technologies as an all-in-one solution for data analysis, interpretation, and reporting.

“Both companies are very much driven to deliver these joint solutions in a clinical diagnostic setting,” commented Congenica’s Chief Business Officer, Shikha O’Brien, Ph.D., on the companies’ mutual commitment to bringing genomics-based medicine to fruition through their individual technologies.

Congenica’s cloud-based software platform, Sapientia, enables clinical geneticists to analyze and interpret the gamut of next-generation sequencing data and generate a comprehensive diagnostic report to support clinical decision-making.

The knowledge base underlying Sapientia aggregates data from its users and places it into a knowledge base that can inform future analyses. However, according to O’Brien, “[Sapientia’s] beauty is that it brings all of the information required for variant interpretation together in a single, dynamic interface. All of this information being held together creates an accurate and in depth audit trail to really support the work of our clinical colleagues.”


Click here to access the rest of this article.

Also of Interest